Latest / The Well-Built Life / Aspartame's Dark Side: Exploring Brain Health Risks
Transcript
- 0:00Speaker 1: Hey everyone, welcome back to The Well-Built Life. I am
- 0:03Speaker 1: Rachel Caldwell, alongside Thomas Bennett, and we are so glad
- 0:06Speaker 1: you are tuning in. We are here to cut through
- 0:09Speaker 1: the noise, skip the intense jargon and extreme rules, and
- 0:13Speaker 1: share simple, practical habits that help you feel stronger, healthier,
- 0:18Speaker 1: and more balanced every single day. Grab a drink, get comfortable,
- 0:22Speaker 1: and let's dive in. So, Thomas, what do you make
- 0:26Speaker 1: of the latest study on aspartame and stroke conditions? It's
- 0:30Speaker 1: quite a nuanced piece of research.
- 0:33Speaker 2: Really. Absolutely, Rachel. Yan Bai and Ji Feng's work at
- 0:37Speaker 2: Fudan University delve deeply into the effects of aspartame on
- 0:41Speaker 2: brain cells during stroke. The key takeaway is that aspartame
- 0:45Speaker 2: seems to exacerbate brain damage by disrupting cellular energy centers
- 0:49Speaker 2: and blocking protective signaling pathways.
- 0:52Speaker 1: Right. And that's the crucial nuance here. The study used mice,
- 0:56Speaker 1: of course, but the mechanisms they observed are quite telling.
- 1:00Speaker 1: they found a 25% larger reduction in cell viability when
- 1:05Speaker 1: aspartame was present during oxygen and glucose deprivation tests.
- 1:09Speaker 2: Exactly which brings up an interesting contradiction. The study looked
- 1:13Speaker 2: at acute exposure over a week, but what about the
- 1:16Speaker 2: long-term daily consumption that many people might experience? Chronic exposure
- 1:21Speaker 2: hasn't been thoroughly explored yet.
- 1:23Speaker 1: That's a valid point. The study noted that mice treated
- 1:27Speaker 1: with 0.2% aspartame had a 58.6% increase in dead tissue
- 1:32Speaker 1: area compared to those given plain water. This suggests a
- 1:36Speaker 1: significant impact. But the real, world relevance of that needs
- 1:40Speaker 1: more research.
- 1:41Speaker 2: And just to complicate things further, the study was only
- 1:44Speaker 2: in male mice. So, we don't know if the findings
- 1:48Speaker 2: might apply to females. Gender-specific research is crucial here.
- 1:52Speaker 1: Definitely. But let's get back to the core findings. The
- 1:56Speaker 1: aspartame disrupts mitochondrial function. leading to increased ROS production and
- 2:01Speaker 1: reduced viability of neural cells. They also found that aspartame
- 2:05Speaker 1: inhibits the ERCREB1 pathway, which is critical for cell survival
- 2:09Speaker 1: during stress.
- 2:10Speaker 2: That's wild when you look at the raw numbers. The
- 2:13Speaker 2: ERCREB1 pathway was suppressed, and when they neutralized ROS and
- 2:17Speaker 2: activated the pathway, they saw a reduction in the detrimental
- 2:21Speaker 2: impact of aspartame. It points to the importance of these mechanisms.
- 2:26Speaker 1: Yes, and it's not all bad news. The study raises
- 2:30Speaker 1: important questions that need answers. For instance, how do these
- 2:34Speaker 1: findings translate to human clinical scenarios? Future research will need
- 2:38Speaker 1: to explore how artificial sweeteners alter metabolic pathways over longer periods.
- 2:45Speaker 2: Right, and that's where the broader debate comes in. Experts
- 2:48Speaker 2: in the field will be discussing the generalizability of the
- 2:51Speaker 2: findings and the significance of aspartame's role in exacerbating brain damage.
- 2:57Speaker 2: Tere's also a lot of uncertainty around chronic exposure and
- 3:00Speaker 2: long-term effects.
- 3:02Speaker 1: Exactly. The study by Yan Bai and Ji Feng adds
- 3:05Speaker 1: a layer of complexity to the aspartame debate. It's clear
- 3:09Speaker 1: Tere's more to learn about its effects on the brain,
- 3:13Speaker 1: and that's going to be the focus of ongoing research. So, Thomas,
- 3:17Speaker 1: diving into the study's methodology, can you help unpack how
- 3:21Speaker 1: they measure the disruption of mitochondrial function and the suppression
- 3:24Speaker 1: of the ERKER-CREB1 pathway? I am really curious about the
- 3:28Speaker 1: nuts and bolts of their experiments.
- 3:30Speaker 2: Absolutely, Rachel. The researchers opted for a multi-faceted approach to
- 3:35Speaker 2: really get to the core of aspartame's impact. They started
- 3:39Speaker 2: with feeding the mice water containing different concentrations of aspartame, 0.1%
- 3:45Speaker 2: and 0.2%, and a control group for a week. This
- 3:49Speaker 2: is a critical period because it mimics chronic consumption over
- 3:53Speaker 2: an extended time frame.
- 3:54Speaker 1: That's interesting. And then, what did they do to induce
- 3:58Speaker 1: the stroke condition?
- 3:59Speaker 2: Right. So after a week, they temporarily clamped the carotid
- 4:03Speaker 2: arteries of the mice, simulating an ischemic stroke, and waited
- 4:06Speaker 2: 12 hours post-stroke before performing tissue analyses. This method allowed
- 4:12Speaker 2: them to assess both acute and subacute effects of aspartame post-stroke.
- 4:17Speaker 1: And what exactly did they find regarding mitochondrial dysfunction?
- 4:22Speaker 2: Well, the study found that aspartame caused a 25% reduction
- 4:26Speaker 2: in cell viability in neurons, especially when tested under conditions
- 4:31Speaker 2: of oxygen and glucose deprivation, essentially mimicking stroke conditions. This
- 4:36Speaker 2: indicates that aspartame weakens the mitochondria, the energy powerhouse of
- 4:41Speaker 2: the cell, leading to increased reactive oxygen species ROS production
- 4:47Speaker 2: and reduced cell survival.
- 4:49Speaker 1: Reactive oxygen species, huh? Can you explain that a bit more?
- 4:53Speaker 2: Sure. ROSE are byproducts of normal metabolic processes and can
- 4:58Speaker 2: lead to oxidative stress when present in excess. In this case,
- 5:02Speaker 2: aspartame seemed to disrupt mitochondrial efficiency, leading to higher levels
- 5:07Speaker 2: of ROSE. This oxidative stress can damage cellular components, potentially
- 5:12Speaker 2: exacerbating the damage caused by the stroke.
- 5:15Speaker 1: That's quite a step. And how did they address the suppression?
- 5:20Speaker 2: The researchers found that aspartame inhibited the activation of the
- 5:24Speaker 2: ERKREB1 pathway, which is crucial for cell survival during stress. Normally,
- 5:31Speaker 2: when a neuron is under threat, this pathway ramps up
- 5:34Speaker 2: to help the cell fend off injury. But the study
- 5:37Speaker 2: showed that aspartame essentially turned down this protective mechanism. leaving
- 5:42Speaker 2: the cells more vulnerable.
- 5:44Speaker 1: And it's interesting to see that when they neutralized the
- 5:47Speaker 1: ROS and reactivated the pathway, the harmful effects of aspartame
- 5:51Speaker 1: were mitigated. That's a key finding, right?
- 5:55Speaker 2: Exactly. It highlights the interplay between ROS production and the
- 5:59Speaker 2: protective signaling pathways. The study was able to partly reverse
- 6:03Speaker 2: the damage by addressing both these mechanisms, suggesting that targeting
- 6:07Speaker 2: one might help alleviate the other's harmful effects.
- 6:10Speaker 1: Very insightful. So, what are the broader implications of these findings?
- 6:17Speaker 1: Do you think?
- 6:17Speaker 2: A lot of uncertainty remains around chronic exposure long-term. The
- 6:22Speaker 2: study focused on short-term effects with an eye toward longer-term research.
- 6:27Speaker 2: It underscores the need for more comprehensive studies to fully
- 6:30Speaker 2: understand the effects of aspartame on human health over time.
- 6:34Speaker 1: Absolutely. It's clear we need more research. But these findings
- 6:39Speaker 1: provide valuable insights for ongoing investigations. Thomas, thanks for walking
- 6:44Speaker 1: through the methodology so clearly. It really helps us understand
- 6:48Speaker 1: the complex mechanisms at play. So, Thomas, the study only
- 6:52Speaker 1: looked at male mice. Do you think the findings could
- 6:55Speaker 1: apply to females? Or could there be gender-specific effects here
- 7:00Speaker 1: that we need to factor in?
- 7:01Speaker 2: Great question, Rachel. Given that most neurotoxicity studies historically undersampled
- 7:07Speaker 2: female subjects, to raise a real concern that these findings
- 7:10Speaker 2: might not be directly translatable to females. Studies have shown
- 7:14Speaker 2: that sex differences can significantly impact cellular and molecular responses,
- 7:18Speaker 2: especially in conditions like stroke. We need more gender-balanced research
- 7:23Speaker 2: to ensure these findings are generalizable.
- 7:25Speaker 1: Definitely. Another limitation is the short-term nature of the study.
- 7:31Speaker 1: The seven-day exposure period, doesn't really mimic the long-term, daily
- 7:36Speaker 1: consumption that many people might experience. How does that affect
- 7:40Speaker 1: our interpretation of the results?
- 7:42Speaker 2: Right, and that's the crucial nuance here. Short-term exposure might
- 7:46Speaker 2: not fully capture the cumulative effects of chronic use. For instance,
- 7:50Speaker 2: it's known that long-term aspartame consumption can lead to metabolic
- 7:54Speaker 2: changes that might not be evident in the acute setting
- 7:57Speaker 2: of the study. This could be particularly relevant for understanding
- 8:01Speaker 2: long-term neurodegenerative processes, exactly which brings up an interesting contradiction.
- 8:07Speaker 2: The lack of behavioral outcomes could mean that the cellular
- 8:10Speaker 2: damage might not necessarily translate to observable symptoms. However, this
- 8:15Speaker 2: doesn't rule out the possibility that chronic exposure to aspartame
- 8:18Speaker 2: could have ongoing, Subtle impacts on cognitive function. It's a
- 8:21Speaker 2: gap in the research that needs to be addressed.
- 8:24Speaker 1: Agreed. And what about the broader debate and perspectives from
- 8:28Speaker 1: experts in the field? How are they responding to these findings?
- 8:32Speaker 2: Experts are wary. Many are calling for more comprehensive studies
- 8:36Speaker 2: that can address the gender-specific effects, long-term exposure, and behavioral outcomes.
- 8:42Speaker 2: Yan Bai mentioned the need for future research to explore
- 8:46Speaker 2: how artificial sweeteners alter metabolic pathways over longer periods. Ji
- 8:51Speaker 2: Feng highlighted that chronic, low-dose exposure might alter the brain's
- 8:55Speaker 2: resilience over a lifetime, which is something we need to evaluate.
- 8:59Speaker 1: That's a good point. It's clear that while the study
- 9:02Speaker 1: provides valuable insights, Therese still a lot to uncover. The
- 9:06Speaker 1: next steps involve more detailed longitudinal research. to really understand
- 9:11Speaker 1: the long-term impacts of aspartame. What do you think, Thomas?
- 9:15Speaker 1: How might these findings influence future consumer behavior and regulatory policies?
- 9:20Speaker 2: It's likely that these findings will prompt stricter scrutiny of
- 9:23Speaker 2: aspartame's safety. Regulatory bodies might call for more stringent testing
- 9:28Speaker 2: before approving any new artificial sweeteners. Consumers, meanwhile, might become
- 9:33Speaker 2: more cautious and look for alternatives. But ultimately, the call
- 9:37Speaker 2: for more research from experts will shape public health guidelines
- 9:41Speaker 2: and consumer choices.
- 9:42Speaker 1: So, looking at future research needs from these findings, it
- 9:46Speaker 1: seems clear that long-term exposure effects will be key. What
- 9:51Speaker 1: do you think, Thomas? How can we best approach this?
- 9:54Speaker 2: Absolutely, Rachel. Long-term studies are crucial. For instance, if Asper
- 10:00Speaker 2: disrupts mitochondrial function and leads to increased ROs, we need
- 10:04Speaker 2: to understand how these effects accumulate over years of consumption.
- 10:09Speaker 2: It's like studying the wear and tear of a car
- 10:11Speaker 2: over its lifetime how small issues lead to bigger problems
- 10:15Speaker 2: down the road.
- 10:15Speaker 1: Right. And that's the crucial nuance here. The FDA and
- 10:20Speaker 1: EFSA might call for longitudinal studies that mimic real-world consumption habits. Right?
- 10:26Speaker 1: Not just short-term exposure.
- 10:29Speaker 2: Precisely. These long-term studies could help us gauge whether the
- 10:32Speaker 2: immediate impacts observed in mice translate to human scenarios. For
- 10:37Speaker 2: example … Could decades of aspartame consumption have similar effects
- 10:41Speaker 2: on cell viability and tissue damage? I wonder if Therese
- 10:44Speaker 2: bin any preliminary data from human observational studies that we
- 10:49Speaker 2: could reference.
- 10:50Speaker 1: It's interesting you mention that. We should explore whether epidemiological
- 10:54Speaker 1: studies have noted any correlations between aspartame consumption and neurological
- 10:59Speaker 1: issues in humans. Thomas, do you have any thoughts on
- 11:02Speaker 1: how these could inform future research?
- 11:04Speaker 2: Absolutely, Rachel. Epidemiological studies would be essential, but they come
- 11:09Speaker 2: with their own set of limitations. Like the mice studies,
- 11:12Speaker 2: humans are more complex. For one, we have other lifestyle
- 11:16Speaker 2: factors that could confound results. However, if we can tease
- 11:20Speaker 2: out a relationship, it would provide a valuable starting point.
- 11:23Speaker 2: Perhaps combining short term animal studies with long term human
- 11:28Speaker 2: population studies could give us a clearer picture.
- 11:31Speaker 1: Definitely. Another angle to consider is the clinical applicability of
- 11:36Speaker 1: these findings. For instance, if aspartame really does disrupt signaling
- 11:41Speaker 1: pathways and increase ROAS, how might this affect patients with
- 11:46Speaker 1: pre-existing conditions, such as diabetes, where neuroinflammation is a concern?
- 11:51Speaker 2: Great point. We need to understand the impact on vulnerable populations.
- 11:56Speaker 2: Imagine a diabetic patient relying on artificial sweeteners. If aspartame
- 12:01Speaker 2: exacerbates brain damage, that could be a significant issue. Clinical
- 12:06Speaker 2: trials focusing on these groups could address these concerns directly.
- 12:09Speaker 1: Exactly. Which brings up an interesting contradiction. If aspartame could
- 12:14Speaker 1: be harmful, does that mean we should outright ban it?
- 12:18Speaker 1: Or is there a balance to be found between health
- 12:20Speaker 1: concerns and consumer preferences?
- 12:22Speaker 2: That's a tough call, Rachel. It's like balancing the benefits
- 12:26Speaker 2: of sugar-free products with the potential risks. One approach could
- 12:30Speaker 2: be to regulate aspartame more strictly, requiring companies to disclose
- 12:35Speaker 2: its presence more clearly and perhaps limiting its use in
- 12:38Speaker 2: certain products. This way, consumers have informed choices and manufacturers
- 12:44Speaker 2: face more scrutiny.
- 12:45Speaker 1: That sounds pragmatic. Ultimately, research should provide us with enough
- 12:50Speaker 1: information to make evidence-based decisions. It's about creating a safer
- 12:54Speaker 1: environment for everyone. not just banning something out of hand.
- 12:59Speaker 2: Agreed, Rachel. The key is to have robust long-term studies
- 13:03Speaker 2: that can guide public health policies and consumer behaviors. It's
- 13:07Speaker 2: all about understanding the nuances and taking a balanced scientific
- 13:11Speaker 2: approach to regulation.
- 13:13Speaker 1: Looking at all these findings, it's clear we are just
- 13:16Speaker 1: scratching the surface of what artificial sweeteners might do. It's
- 13:20Speaker 1: a complex interplay of different mechanisms that could have big
- 13:23Speaker 1: implications for public health.
- 13:25Speaker 2: Absolutely. Take aspartame, for instance. It's not just about the
- 13:29Speaker 2: short-term effects during a simulated stroke. The long-term exposure questions
- 13:34Speaker 2: are equally pressing. The idea that it might suddenly alter
- 13:38Speaker 2: metabolic pathways over time is really concerning.
- 13:41Speaker 1: Definitely. And the fact that these long-term effects haven't been
- 13:45Speaker 1: fully studied yet is a massive gap. If aspartame disrupts
- 13:49Speaker 1: mitochondrial function enough to increase RAUAs and degrade neural viability,
- 13:54Speaker 1: What does that mean for daily consumption?
- 13:55Speaker 2: Great point. It suggests that even something as seemingly innocuous
- 14:00Speaker 2: as a zero-calorie drink might have far-reaching consequences. And the
- 14:04Speaker 2: gender-specific effects are particularly interesting. If these findings hold up,
- 14:09Speaker 2: it could lead to more tailored public health recommendations, right?
- 14:12Speaker 1: Exactly personally tailored advice based on sex and possibly age.
- 14:16Speaker 1: But on a broader scale, it could push us towards
- 14:19Speaker 1: more targeted and personalized health interventions in the future. Speaking
- 14:24Speaker 1: of which, how do you think health organizations should proceed
- 14:27Speaker 1: with education and public policy?
- 14:29Speaker 2: Well, Rachel, it's a tricky balance. They need to convey
- 14:33Speaker 2: that while the evidence is compelling, it's not definitive. But
- 14:37Speaker 2: they also can't ignore the potential risks. A balanced approach
- 14:41Speaker 2: might be to promote moderate use and continue to fund
- 14:44Speaker 2: long-term research.
- 14:45Speaker 1: That makes sense. And for consumers, it's crucial to stay
- 14:49Speaker 1: informed and make educated choices. Maybe we can produce some
- 14:53Speaker 1: tips and guides on how to navigate this safely, perhaps
- 14:57Speaker 1: focusing on moderation and being mindful of other health factors.
- 15:01Speaker 2: Absolutely. And what about the companies that produce these sweeteners?
- 15:06Speaker 2: How should they respond?
- 15:07Speaker 1: They should be transparent about their research and development processes.
- 15:11Speaker 1: Showing a commitment to ongoing studies and safety could help
- 15:15Speaker 1: maintain consumer trust. Plus, to raise an opportunity here for
- 15:19Speaker 1: innovation in safer, non-nutritive sweeteners that don't carry the same
- 15:24Speaker 1: health risks. True.
- 15:27Speaker 2: And as for policy, we might see changes in regulatory frameworks,
- 15:31Speaker 2: especially if more studies confirm these findings. Countries like the
- 15:36Speaker 2: EU already have strict guidelines the U.S. might follow suit.
- 15:40Speaker 1: Right. It's all about evolving our understanding and adapting to
- 15:44Speaker 1: new scientific insights. This isn't about demonizing artificial sweeteners, but
- 15:49Speaker 1: rather putting them in perspective, and recognizing their complex role
- 15:53Speaker 1: in our health.
- 15:53Speaker 2: Exactly. So as we head into the future, let's hope
- 15:57Speaker 2: these lessons lead to safer, more informed choices for everyone.
- 16:01Speaker 1: That brings us to the end of today's episode. Thank
- 16:03Speaker 1: you so much for spending part of your day with me.
- 16:06Speaker 1: If you found this episode's tips helpful and want to
- 16:09Speaker 1: make sure you don't miss the next conversation, please take
- 16:12Speaker 1: a quick second to hit that subscribe or follow button
- 16:15Speaker 1: on whatever platform you are listening on, It's a completely
- 16:18Speaker 1: free way to support the show and helps more people
- 16:21Speaker 1: find us. This podcast is independently produced, so if you
- 16:25Speaker 1: are ever in a position where you would like to
- 16:27Speaker 1: help keep it running, we do accept small donations. You
- 16:30Speaker 1: can find a link right in the episode description below
- 16:33Speaker 1: to buy us a coffee or contribute what you can.
- 16:36Speaker 1: Every bit genuinely helps. Take care of yourself, stay balanced,
- 16:40Speaker 1: and we will talk again soon.